Mahady, Redmond move up at Wyeth

Share this article:
Wyeth named Joe Mahady president, Wyeth Pharmaceuticals and SVP, Wyeth.

In February, Mahady was named president, global business for the company's pharmaceuticals division, with responsibility for all worldwide commercial business. Prior to that, he was president, Americas and global business, in which role he presided over steep cuts in the company's US primary care sales force, supplemented by the hiring of flex-time reps. He joined the company in 1979 as a pharmacist with its regulatory affairs division.

Also moving up are Wyeth BioPharma head Cavan Redmond, who becomes president, Wyeth Consumer Healthcare, and Richard DeLuca, who becomes president, Fort Dodge Animal Health.

They will assume their new roles Jan. 1, the day Bernard Poussot takes the reins from CEO Bob Essner, who is retiring.

Share this article:

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.